[TetaVi in Vents] Meet Eden Hadad, the Volumetric Production Director at Tetavi Oct 14, 2022 | News Center Share: Read more here.
![[Biolojic in BioSpace] Interim results from phase 1/2 clinical trial in solid tumor cancers demonstrate Aulos Bioscience’s AU-007 is well tolerated and uniquely reduces regulatory T Cells](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
